Study of Factors Linked to Death in Trauma Patients Admitted to the Intensive Care Unit in Villavicencio, Colombia
Led by Hospital Departamental de Villavicencio · Updated on 2026-05-27
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the factors linked to severe trauma outcomes, including mortality, among patients admitted to intensive care units ICUs in general hospitals across the Colombian Orinoco region. This study focuses on trauma, the leading cause of death and disability in young populations worldwide, often caused by violence and vehicle accidents. By analyzing trauma admissions and comparing them to other ICU admissions, the study aims to identify key predictors of trauma mortality and outcomes.
The study involves reviewing ICU discharge records over a two-year period from January 2022 to December 2024 at two hospitals in Villavicencio, Colombia. Patients are grouped into those admitted for trauma-related reasons and those admitted for other diagnoses. The researchers will analyze demographic data, severity scores, and diagnoses to understand differences and factors associated with trauma outcomes.
Participants medical records will be examined to assess mortality within 30 days and length of ICU stay. The study will highlight causes of trauma admissions, severity, and outcomes for different trauma types. The goal is to develop a predictive model tailored to the local population to help improve resource allocation, treatment strategies, and potentially reduce mortality and complications. The study extends through 2028 and is observational, reviewing existing hospital data without direct patient intervention.
CONDITIONS
Brief Title
Mortality of Trauma in the Intensive Care Unit.
Research Team
N
Norton Perez Gutierrez, MD
E
Emma I Rodriguez Darabos, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surveillance
Duration - Up to 30 days
Participants who undergo routine intensive care unit admission are observed and their records reviewed to analyze factors associated with trauma mortality and ICU length of stay.
Observation of hospital stay with no additional visits required
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Comparing SupraSDRM4 and NovoSorb4 BTM Dressings to Promote Healing and Shorten Grafting Time in Full-Thickness Wounds
Study to Evaluate a 3D Surgical Planning Tool for Complex Tibia Fractures Using Patient CT Scans
Pilot Study of Electrical Impedance Tomography for Soft Tissue Injury After High Energy Extremity Fractures
Evaluating EMTRAS, REMS, and GAP Scores to Predict Outcomes in Trauma Patients in Iraq
A Prospective Multicenter Study on Mortality, Intubation, and Hospital Stay Length
Study of Immune Cell Dysfunction and Myeloid-Derived Suppressor Cells in Surgical Sepsis and Trauma
Evaluating a Self-Management Support Program for Adults After Moderate to Severe Traumatic Injury
A Pragmatic Randomized Trial at Oslo University Hospital
Study of Bone Marrow Stem Cell Changes After Severe Injury and Hip Repair in Adults
Study of Inflammation, Lung Function, and miRNA-126 Levels in Adults After Trauma
Massive Transfusion in Children Comparing Whole Blood and Component Therapy with Tranexamic Acid or Placebo in Severe Traumatic Bleeding
Study of Factors Linked to Death in Trauma Patients Admitted to the Intensive Care Unit in Villavicencio, Colombia
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The effectiveness of FOUR score versus GCS scale in predicting mortality and morbidity in traumatic brain injured patients in intensive care: A systematic review.
Mariana Sofia Nunes Dos Santos, Louise Caroline Stayt
ESTES recommendations for the treatment of polytrauma-a European consensus based on the German S3 guidelines for the treatment of patients with severe/multiple injuries.
Cristina Rey Valcarcel, Dan Bieler, Gary A Bass...
Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.